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Abstract
Introduction: The relative contributions of CD4+ and CD8+ T cells to transplant rejection remain unknown. The authors inte-
grated a previous model of CD4-mediated graft rejection with a complementary model of CD8-mediated rejection to direct-
ly compare the function of graft-reactive CD4+ and CD8+ lymphocytes in vivo in a model where rejection requires transgenic
T cells. These studies allow direct comparison of CD4 and CD8 T cell responses to the same antigen without the confound-
ing effects of T cell depletion or homeostatic proliferation.
Materials and Methods: Clone 4 and TS1 mice possess MHC class I- and II-restricted CD8+ and CD4+ T cells, respectively,
which express transgenic T cell receptors that recognize the influenza hemagglutinin antigen (HA). We compared the in vivo
response of CFSE-labeled, HA-specific transgenic CD8+ and CD4+ T cells after adoptive transfer into syngeneic
BALB/c mice grafted with HA-expressing skin. 
Results: As in the authors’ CD4+ model, HA104 skin was consistently rejected by both Clone 4 mice (n=9, MST: 14.2) and
by 5×105 Clone 4 lymphocytes transferred to naive BALB/c hosts that do not otherwise reject HA+ grafts. Rejection corre-
lated with extensive proliferation of either graft-reactive T cell subset in the draining lymph nodes, and antigen-specific
CD4+ and CD8+ cells acquired effector function and proliferated with similar kinetics. 
Conclusions: These data extend the authors’ unique transgenic transplantation model to the investigation of CD8 T cell func-
tion. The initial results confirm fundamental functional similarity between the CD4 and CD8 T cell subsets and provide
insight into the considerable redundancy underlying T cell mechanisms mediating allograft rejection. 
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INTRODUCTION
While our understanding of the cellular basis of allo-
graft rejection continues to grow, the relative contribu-
tions of CD4+ and CD8+ T cell subsets to this process
remain unclear. Though current evidence suggests that
the collaboration of CD4+ and CD8+ T cells maximizes
graft rejection [9, 21], either population alone can medi-
ate rejection under particular conditions [11–14, 20, 22,
27]. CD4+ and CD8+ T cells also exhibit differential
sensitivity to calcineurin inhibitors [3], respond differ-
ently to suppression by CD4+CD25+ T regulatory cells
[19], and possess different costimulatory and growth fac-
tor requirements [24]. Hence an improved understand-
ing of how these subsets cooperatively respond to
alloantigen may allow the development of more com-
prehensive immunosuppression strategies that minimize
graft rejection and systemic toxicity by optimally target-
ing both effector subsets.
Difficulty elucidating the relative contributions of
CD4+ and CD8+ T cells in allograft rejection relates in
part to the models used to study their involvement.
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CD8+ monoclonal antibodies or CD4+/CD8+ knockout
mice to determine whether allograft rejection occurs in
the absence of either subset [11, 13]. Unfortunately,
these approaches have similar limitations in that 1) they
do not allow differentiation of donor-reactive T cells
from the more abundant non-reactive host T cell reper-
toire, 2) direct comparison of the activation kinetics of
CD4+ and CD8+ subsets cannot be made, and 3) home-
ostatic proliferation in the immunodeficient host may
confound experimental results [4, 26]. More recently,
a transgenic model of allograft rejection suggested fun-
damental functional similarity between CD4 and CD8
T cells [9]. However, this model was also confounded by
rejection in the absence of the transgenic T cells, leaving
an open question regarding the function and phenotype
of CD4 and CD8 T cells actively involved in mediating
graft rejection.
An alternative approach circumventing these con-
cerns is the transfer of graft-specific CD4+/CD8+ T cells
into immunocompetent hosts that do not otherwise
reject their allografts, a unique experimental setting that
we previously defined for CD4 T cells [14, 15]. This
strategy has several potential advantages. First, the abil-
ity of each T cell subset to independently reject an allo-
graft can be assessed by transferring only CD4+ or
CD8+ T cells. Second, the labeling of graft-reactive cells
prior to transfer allows them to be visualized and
tracked to determine whether CD4+ and CD8+ respon-
ders behave similarly in vivo. Third, manipulation of the
recipient immune system with depleting antibodies or
the use of immunodeficient hosts is not required.
Finally, in our model, graft-reactive T cells are absolute-
ly required for graft rejection. To investigate the inter-
play of CD4+ and CD8+ T cells in graft rejection, we
developed a model of transplant rejection based on the
transfer of antigen-specific CD8+ T cells to immuno-
competent hosts which complements our existing CD4+
model [14, 15]. In this study we use this model to direct-
ly compare the activation and function of CD8+ and
CD4+ effector cells responding to a common antigen in
vivo. 
MATERIALS AND METHODS
Animals
HA104 transgenic mice, developed by Caton et al.
[5], contain DNA encoding the full-length influenza
virus A PR8 hemagglutinin antigen (HA) polypeptide
linked to the SV40 early region promoter-enhancer.
Translation of this transgene product results in ubiqui-
tous HA expression on all tissues in HA104 mice. Thy
1.1+ Clone 4 T cell receptor (TCR) transgenic mice
were generously provided by Linda A. Sherman (The
Scripps Research Institute, La Jolla, CA). Clone 4 mice
possess a high frequency of MHC class I Kd-restricted
CD8+ T cells which express a transgenic TCR (Vα10,
Vβ8.2) specific for the HA512–520 epitope [18]. TS1 trans-
genic mice possess a high frequency of CD4+ T cells
specific for the immunodominant (Site 1, HA110–120) epi-
tope of the influenza HA protein in the context of MHC
class II I-Ed [14]. All transgenic mice were bred onto the
BALB/c background, and transgene expression in graft
donors or recipients was detected by either flow cytom-
etry (Clone 4, TS1) or polymerase chain reaction
(HA104). Immunocompetent BALB/c mice (H-2d) were
obtained from the Jackson Laboratory (Bar Harbor,
ME). All mice were housed and maintained according
to the guidelines established by the Institutional Animal
Care and Use Committee of the University of
Pennsylvania.
Flow cytometric analysis
Single-cell suspensions were prepared from periph-
eral lymph nodes and labeled with fluorochrome-conju-
gated antibodies for flow cytometric examination. The
following antibodies were used in the analysis: peridinin
chlorophyll protein-conjugated anti-CD8 (clone
53–6.7), allophycocyanin (APC)-conjugated anti-CD4
(clone RM4-5), R-phycoerythrin (PE)-conjugated anti-
-Thy 1.1 (clone OX-7), PE-conjugated anti-interferon
(IFN)-γ (B27), and PE-conjugated anti-Vβ8.1, 8.2
(clone MR5-2; PharMingen, San Diego, CA). PE-conju-
gated anti-Perforin (clone eBioOMAK-D) was pur-
chased from eBioscience (San Diego, CA). Thy 1.1
Clone 4 transgenic T cells could be identified after
transfer into BALB/c mice (Thy 1.2) using anti-Thy 1.1
antibody, and the transgenic TCR could be specifically
identified after labeling with anti-Vβ8.1, 8.2 antibody.
The transgenic TS1 TCR was detected using 6.5 biotin
(GibcoBRL) and streptavidin-APC (PharMingen, San
Diego, CA).
Animal procedures and histological examination
As described initially by Billingham and Medawar
[1], skin was grafted to the lateral thoracic area of anes-
thetized mice. Graft size, presence of hair, and scabbing
were sequentially monitored and recorded. Graft rejec-
tion was defined as greater than 75% graft destruction. 
Fluorescent labeling
Labeling with carboxyfluorescein succinimidyl ester
(CFSE) was performed as previously described [16].
CD4+ T cell depletion
500  µg of anti-CD4 depleting antibody (GK1.5,
Bioexpress, West Lebanon, NH) was injected intraperi-
toneally into target mice on day 5 prior to skin grafting.
Depletion of the CD4 T cell compartment in both
peripheral lymph nodes and the blood was confirmed by
flow cytometry prior to skin transplantation. Injections
were repeated every 5 days until sacrifice.
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Average duration of graft survival is reported as the
mean survival time (MST). Graft survival among groups
was compared according to the method of Kaplan and
Meier using the log-rank test. Fisher’s exact test and
Student’s t-test (2-tailed) were used to compare cate-
gorical and continuous variables, respectively, where
appropriate. Statistical analysis was performed with
SPSS software (version 11.0, Chicago, IL). P values less
than 0.05 were considered statistically significant. 
RESULTS
Transgene-positive Clone 4 mice reject HA104 
skin grafts in an antigen-specific fashion
Given the high frequency of HA-specific CD8+
T lymphocytes known to circulate in transgene-positive
(Tg+) Clone 4 mice [18], we hypothesized that HA104
skin grafts would be rapidly rejected by Tg+ Clone 4
hosts in an antigen-specific fashion. We observed con-
sistent and vigorous rejection of HA104 skin grafts by
Tg+ Clone 4 mice (n=9, MST: 14.2 days; Fig. 1).
Rejection correlated with a dense mononuclear cellular
infiltrate consistent with acute cellular rejection (data
not shown). Transgene-negative Clone 4 littermates
(Thy 1.1+) accepted HA104 grafts (Thy 1.2+) indefinite-
ly, indicating that rejection is dependent on the expres-
sion of the transgene-encoded TCR (n=3, MST>100
days, p=0.006 vs. transgene-positive animals; Fig. 1).
Additionally, HA-negative BALB/c skin transplanted to
Tg+ Clone 4 mice was accepted indefinitely (n=4, data
not shown). Collectively, these results indicate that both
transgenic Clone 4 T cells and graft expression of HA
are required for rejection in this model. 
To exclude the possibility that CD4+ T cells express-
ing the transgenic TCR in the Clone 4 mouse were also
required for allograft rejection in this system, we elimi-
nated CD4+ lymphocytes from Clone 4 hosts prior to
transplant using the depleting anti-CD4+ antibody
GK1.5. CD4-depleted hosts remained capable of reject-
ing HA+ skin grafts, indicating that CD8+ cells are capa-
ble of independently mediating rejection in transgene-
positive Clone 4 hosts (2/4 reject, MST: 26.5). That rejec-
tion by depleted animals is somewhat less consistent and
occurs with a delayed tempo suggests that CD4+ T cells
may enhance the response and that this model may allow
future exploration of subset cooperativity. 
Collectively, these results indicate that CD8+ T cells
from Clone 4 hosts consistently reject HA104 skin
grafts. Rejection is dependent on expression of the
trangene-encoded TCR and HA expression in the graft.
That CD4-depleted Clone 4 mice remain capable of
rejecting skin grafts suggests that CD8+ T cells alone are
capable of mediating rejection.
Clone 4 Tg+ mice develop antigen-specific 
immunological memory
To confirm that graft rejection by the Clone 4 trans-
genic mouse mimics cellular rejection in normal non-
transgenic hosts, we evaluated whether Clone 4 hosts
develop a memory response to HA antigen. When Tg+
Clone 4 mice that had previously rejected HA104 skin
were regrafted with HA104 skin, graft rejection recurred
with a significantly accelerated tempo, consistent with an
anamnestic response (n=7, MST: 8 days, p=0.008 vs.
naïve Clone 4 hosts). We subsequently demonstrated
that this memory response could be transferred into syn-
geneic BALB/c hosts who do not reject HA104 skin.
Following complete rejection of HA104 skin grafts,
5×105 lymphocytes from Tg+ Clone 4 hosts were isolat-
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Fig. 1. Rejection of acute HA104 skin
transplants by Clone 4 lymphocytes.
Clone 4 or BALB/c mice were trans-
planted with skin grafts harvested
from HA104 mice. In the adoptive
transfer experiment, lymph nodes
were harvested from Clone 4 mice,
single cell suspensions were pre-
pared, and 5×105 cells were trans-
ferred by tail vein injection into
BALB/c mice bearing HA104 skin
grafts. Control mice are transgene-
-negative Clone 4 littermates grafted
with HA104 skin who did not receive
adoptively transferred cells. Graft
survival was significantly different
between transgene-negative litter-
mates and all other groups (p<0.002,
log-rank test). These data demon-
strate the requirement for HA-reac-
tive transgenic T cells and HA-
-expressing skin grafts for rejection.
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with HA104 skin. These mice promptly rejected the
HA104 skin graft with kinetics identical to the directly
regrafted Tg+ Clone 4 mice (3 of 4 host mice rejected,
MST: 9 days, p>0.05 compared with directly regrafted
animals). Taken together, these results indicate that
rejection of HA104 skin by Clone 4 hosts duplicates
a normal physiological immune response with respect to
the development of immunological memory.
Adoptively transferred Clone 4 lymphocytes reject HA104
skin graft
Having established that Clone 4 hosts consistently
reject HA104 skin grafts, we next established an adop-
tive transfer model in the CD8 transgenic system analo-
gous to that described previously for the CD4+ TS1 sys-
tem [14, 15]. The adoptive transfer model has a number
of advantages. Most notable are that rejection is medi-
ated by a more physiological number of T cells and that
labeling graft-reactive cells prior to transfer allows eval-
uation of their activation in vivo. This model represents
a refinement over previous investigations as the trans-
genic transferred T cells are required to mediate rejec-
tion as non-transgenic animals do not reject HA+ skin
(Fig. 1).
As we had previously demonstrated that 5×105 adop-
tively transferred CD4+ T cells from TS1 hosts consis-
tently reject HA104 skin grafts [14], we determined
whether this number of Clone 4 lymphocytes would also
mediate rejection. 5×105 unfractionated Clone 4 lym-
phocytes transferred into BALB/c recipients grafted one
day prior with HA104 skin consistently mediated rejec-
tion with a tempo similar to that observed in directly
transplanted Clone 4 Tg+ recipients (3/4 rejected, MST:
18.3 days; Fig. 1). Further investigation suggested that
5×105 transferred cells was near optimal for rejection as
progressively decreasing the transferred cell number to
7.5×104 led to less consistent graft rejection (Fig. 2). We
therefore utilized transfers of 5×105 cells for further
experiments. Flow cytometric analysis demonstrated that
Thy 1.1+ Clone 4 lymphocytes constituted on average
0.35% of peripheral CD8+ T cells in BALB/c hosts at two
weeks following cell transfer (data not shown). Thus,
rejection of HA-expressing grafts is maintained when the
precursor frequency is decreased to better recapitulate
the prevalence of TCRs reactive against minor determi-
nants. 
Rejection of HA104 skin grafts correlates 
with proliferation of Clone 4 CD8+ T cells 
in the draining lymph node
As mentioned, a principle advantage of the adoptive
transfer model is the ability to visualize the function and
activation of transferred graft-reactive T cells.
Specifically, labeling lymphocytes prior to transfer with
the fluorescein-based dye CFSE allows visualization and
quantitative assessment of proliferation [16]. We next
evaluated the in vivo activation of Clone 4-derived
CD8+ T cells and compared this with our results using
CD4+ T cells from TCR transgenic TS1 hosts [15].
To analyze the localization and activation of trans-
ferred Clone 4 lymphocytes, 5×105 unfractionated
CFSE-labeled Clone 4 lymphocytes were transferred to
BALB/c hosts grafted one-day prior with HA104 skin.
Axillary and inguinal lymph nodes ipsilateral and con-
tralateral to the HA104 skin graft were harvested 14
days post-cell transfer and the proliferation of trans-
ferred cells was evaluated at each site using flow cytom-
etry. We observed an extensive proliferative response
among transferred cells that was largely restricted to the
draining lymph node (>7 rounds of division; Fig. 3A).
While many cells divided 6+ times in the draining
lymph node, few cells reached 4+ divisions in contralat-
eral lymph nodes (Fig. 3B). Proliferation was restricted
to CD8+ T cells, as the cells expressing low levels of
CD8, a majority of which would be CD4+ T cells, under-
went very few rounds of division (Fig. 3A, CD8lo popu-
lation), providing evidence that the cells proliferating in
response to the graft were Clone 4 lymphocytes bearing
the transgenic TCR. The observed proliferative
response was highly antigen specific, as the frequency of
mitotic events amongst HA-specific T cells in the trans-
fer inoculum (best identified by the expression of the
transgene-encoded TCR β chain Vβ8.2) was significant-
ly higher than that among non-HA-specific cells (avg.
number of mitoses/10,000 cells: 5556 Vβ8.2+ vs. 1055
Vβ8.2–, n=3, p=0.02; Figs. 3C and D). The extent of
antigen-specific proliferation of Clone 4 cells (>7 divi-
sions) as well as the restriction of proliferation primari-
ly to the draining lymph node were comparable to the
results observed in our previously established TS1
model (Figs. 3E and F). While comparison of Figs.
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Fig. 2. The frequency of rejection of HA104 skin grafts is propor-
tionately increased by the transfer of Clone 4 lymphocytes.
Unfractionated Clone 4 lymph node cells were counted and trans-
ferred into immunocompetent BALB/c recipients that were graft-
ed with HA104 skin. Skin-graft survival was monitored daily until
rejection. Surviving skin grafts were monitored for two months
after cell transfer.
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more proliferation of Clone 4 CD8+ cells in the con-
tralateral lymph node compared with TS1 CD4+ cells,
this response was highly variable. Whether the prolifer-
ation of CD8 T cells is less tightly restricted than that of
CD4 cells would require further investigation.
Collectively, these data indicate that transferred CD8+
T cells from Clone 4 hosts are dynamically comparable to
transferred CD4+ T cells from TS1 hosts [14]. Both popu-
lations divided extensively to HA-expressing skin grafts,
and proliferation in both instances was highly antigen-spe-
cific and largely localized to the draining lymph node.
CD4+ and CD8+ T cells proliferate with similar kinetics
early in the rejection response
The successful development of this antigen-specific
model of CD8-mediated rejection provided the unique
opportunity to directly compare the proliferative
responses of individual CD4+ and CD8+ T cell subsets
to a common antigen in vivo. We demonstrated that the
proliferation of CD8 and CD4 T cells to HA antigen was
comparable at 14 days post-transplant. However, this
late time point could represent the peak response, and
there may still be differences in the kinetics of activation
of CD4 and CD8 T cells post-transplant. We therefore
quantitatively examined the kinetics of the proliferative
response of each of these T cell subsets to determine
whether antigen-specific proliferation of the CD8+
T cells mediating graft rejection would parallel that
observed in the TS1 CD4+ T cell subset. 
Immunocompetent syngeneic BALB/c host mice
grafted with HA104 skin received unfractionated CFSE-
labeled TS1 or Clone 4 lymphocytes one day after skin
transplantation. Recipients were euthanized 5 and 10
days after cell transfer, and the proliferative response at
the draining ipsilateral axillary and inguinal, contralat-
eral axillary and inguinal, and distant cervical lymph
node sites was assessed by flow cytometry. 
Five days after cell transfer, CFSE-labeled lympho-
cytes from both TS1 and Clone 4 mice could be detected
in the cervical, ipsilateral, and contralateral lymph nodes
of all recipient BALB/c host mice. At this early time
point, the CFSE-labeled transgenic T cells of either
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Fig. 3. Clone 4 and TS1 lymphocytes proliferate in the
draining lymph node in response to HA104 skin grafts.
5×105 unfractionated CFSE-labeled Clone 4 lymph node
cells were transferred to BALB/c hosts grafted one day
prior with HA104 skin transplants. The proliferative
response within the ipsilateral (A) and contralateral (B)
inguinal and axillary lymph nodes was assessed 14 days
after cell transfer. Proliferation is largely restricted to the
CD8+ cells (upper right quadrant); CD8lo (presumptive
CD4) cells exhibit little proliferation in this model.
Refined analysis examined the proliferative response of
Vb8+ T cells which also detects the transgenic TCR.
While there was little proliferation of Vb8+ cells against
a BALB/c skin graft (C), these cells demonstrated exten-
sive proliferation driven by HA-expressing skin (D).
Proliferation was largely restricted to the Vb8 expressing
T cells as shown demonstrating preferential activation of
the transgenic TCR. For comparison, 5×105 unfraction-
ated CFSE-labeled TS1 lymph node cells were trans-
ferred to BALB/c hosts grafted one day prior with HA104
skin transplants. The proliferative response within the
ipsilateral (E) and contralateral (F) inguinal and axillary
lymph node was assessed 14 days after cell transfer. As
expected, proliferation is restricted almost exclusively to
the CD4+ population; little proliferation is seen among
CD4lo (presumptive CD8) cells in these dot plots. Each
experimental condition was replicated on at least four
separate occasions.
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number of mitoses per 104 events at ipsilateral lymph
nodes: 226 for TS1 (n=5) and 360 for Clone 4 (n=3),
p=0.44; Fig. 4). Ten days after cell transfer, both the TS1
and Clone 4 transgenic T cell populations demonstrated
increased proliferation restricted to the ipsilateral lymph
nodes (avg. mitoses per 104 events: 769 for TS1 (n=5)
and 2399 for Clone 4 (n=5); Fig. 4). Division for both
populations was significantly increased relative to day 5
(p=0.05 for Clone 4, p<0.0001 for TS1). There was no
significant difference between the proliferation of Clone
4 and TS1 lymphocytes at day 10 post-transplant (p=0.09)
although there was a trend toward a more rapid CD8
response (Fig. 4). Therefore, these data indicate that the
similar pattern of activation for TS1 and Clone 4 lymph
node cells that was initially observed at day 14 post-trans-
plant extends to the early post-transplant period. 
CD4+ and CD8+ T cells acquire effector function 
with similar kinetics during the course 
of antigen-specific proliferation
Our data suggest that both CD4+ and CD8+ T cells
proliferate with similar kinetics in vivo to a common
alloantigen. To determine whether these cells also
acquire effector function in a similar fashion, we stimu-
lated CFSE-labeled Clone 4 and TS1 lymphocytes in
vitro with HA peptide for 72 h and measured intracellu-
lar perforin and IFN-γ, respectively. Consistent with
prior work linking effector function with proliferation
[2, 10], IFN-γ was upregulated after multiple rounds of
cellular division within the CD4+ T cells. Acquisition of
effector function in the CD8+ compartment mirrored
these findings, as perforin protein levels peaked after
approximately four rounds of division (Fig. 5). These
data suggest that CD4 and CD8 cells not only prolifer-
ate with similar kinetics to the same antigen, but also
acquire effector function in a similar manner.
DISCUSSION
Here we present the development of a novel model of
CD8-mediated skin-graft rejection which allows a direct
comparison of CD4+ and CD8+ T cell responses in vivo to
skin grafts bearing a common target antigen. This model
represents an important new system for the investigation
of CD8 and CD4 T cell function as graft-reactive trans-
genic T cells are absolutely required for graft rejection. As
cells are transferred into immunocompetent hosts, this
model is also protected from the confounding effects of
T cell depletion and homeostatic proliferation. Using
CFSE-labeling of the graft-reactive T cell subsets, we
demonstrate that skin-graft rejection correlates with the
clonal proliferation of either a CD4+ or a CD8+ antigen-
-specific T cell population within the graft’s draining lymph
nodes, and that both CD4+ and CD8+ T cells proliferate
with similar kinetics in response to an allograft. In support
of the work of other investigators who have correlated
antigen-specific clonal proliferation by CD4+ T cells with
subsequent acquisition of T cell effector function [2, 10],
we demonstrate that the acquisition of effector function
by CD8+ T cells is also linked to division cycle. 
Our observation that CD4+ and CD8+ T cells both
accumulate and proliferate within the graft’s draining
lymph node is in agreement with findings by Ehst et al.
[9], who studied the rejection of ovalbumin 
(OVA)-expressing skin grafts following the adoptive
transfer of OVA-specific MHC class I- and II-restricted
transgenic T cells (OT-I and OT-II, respectively) into
B6 hosts. However, they were unable to reach a defini-
tive conclusion with respect to graft-reactive cell activity
as the transferred transgenic cells were not required for
graft rejection. These investigators further demonstrat-
ed that co-transfer of both transgenic T cell subsets
resulted in faster graft rejection than transfer of either
T cell subset alone and attributed the accelerated rejec-
tion to a dramatic increase in skin-graft infiltration by
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Fig. 4. Kinetics of TS1 and Clone
4 lymphocyte proliferation to
HA104 skin grafts. 5×105 unfrac-
tionated CFSE-labeled TS1 or
Clone 4 lymph node cells were
transferred to BALB/c hosts
grafted one day prior with
HA104 skin transplants. The pro-
liferative response within the
draining ipsilateral axillary plus
inguinal lymph nodes 5 or 10
days after cell transfer is shown.
TS1 histograms are gated on
CFSE-positive, CD4+ T cells
expressing the transgenic TCR
(6.5+). Clone 4 histograms are
gated on CFSE-positive, CD8+
T cells expressing the transgenic
TCR β chain (Vβ8.2+). The fig-
ures shown are representative of
three separate experiments.
TS1 TS1 TS1
Clone 4 Clone 4 Clone 4
Day 5 Day 10 Day 14
CFSE
TS1
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CD4+ T cell-subset. Thus, CD4+ T cells accelerated
rejection in this model by augmenting the generation
and/or migration of graft-specific CD8+ T cells.
Whether the co-transfer of TS1 and Clone 4 transgenic
T cell populations accelerates skin-graft rejection or
modulates the proliferative response of either popula-
tion is currently under investigation in our laboratory.
Our finding that CD4-depleted Clone 4 hosts rejected
HA+ skin grafts slightly less rapidly and consistently
than intact mice supports a role for CD4/CD8 coopera-
tion in rejection [17]. However, our finding that CD8
cells had as rapid a response as CD4 cells in isolation
suggests that the CD4-CD8 interaction may be more
bipartisan than previously appreciated, with CD8 cells
also serving to enhance CD4 function [25]. 
Our findings also have mechanistic implications for
the observation that monotherapy with anti-CD4 or
anti-CD8 is relatively ineffective in inducing tolerance
to skin allografts [6]. As CD4 and CD8 T cells demon-
strate contemporaneous activation in this transplant set-
ting, inhibition of one subset may have only limited
effect on the other. In contrast, in other tissue allograft
settings where anti-CD4 is more effective [7], there may
be a delay in CD8 kinetics and CD4 dependency. This
hypothesis can be definitively tested with this new model
system and is under investigation. These studies may
define the optimal targets of and timing for
immunotherapy in transplantation settings based on
kinetic data. Moreover, this model system may allow us
to more effectively distinguish the participation of these
cellular subsets in a variety of transplant settings. As we
have already established HA-based models of transplant
rejection in skin, heart, and liver systems, this model
could be expanded to those settings [8, 14, 23]. Whether
cellular grafts such as islets will also be successfully
explored with these methods will require future testing
and refinement.
In conclusion, through the integration of two indi-
vidual models of antigen-specific CD4 and CD8-mediat-
ed graft rejection, we demonstrate remarkable similari-
ty in the cellular mechanisms utilized by CD4+ and
CD8+ T cells to acquire effector function and mediate
antigen-specific graft rejection. Taken together, these
data indicate considerable redundancy in the immune
system’s ability to mediate graft rejection and suggest
that pharmacological therapy which may suppress either
but not both of these T cell subsets may ultimately fail.
Future immunotherapy designed to promote allograft
survival should therefore target both T cell subsets
simultaneously in order to maximize transplantation
success. 
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